CHPT vs TSHA · rev $217.9M vs $640.7M cap
ChargePoint Holdings Inc (CHPT) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported CHPT revenue for 2026-07-31 was $217.9M. Net income was -$78.8M. CHPT currently screens at market cap $199.2M.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
CHPT currently screens at market cap $199.2M. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the CHPT and TSHA stock pages for the full models.
Not investment advice.